Table 1. Patients’ baseline characteristics at inclusion.
| Characteristics | N=16 (%) |
|---|---|
| Age (years)* | 55.5 (43-70) |
| Gender | |
| Male | 12 (75) |
| Female | 4 (25) |
| WHO PS score | |
| 0 | 8 (50) |
| 1 | 7 (44) |
| 2 | 1 (6) |
| Tobacco | |
| Yes | 11 (69) |
| No | 5 (31) |
| Histology of primary tumor | |
| Squamous | 6 (37) |
| Adenocarcinoma | 8 (50) |
| Others | 2 (13) |
| TNM classification (Stage IIIB: n=16) | |
| T2N3M0 | 3 (19) |
| T3N2M0 | 1 (6) |
| T4N0M0 | 3 (19) |
| T4N2M0 | 5 (31) |
| T4N3M0 | 4 (25) |
| Pulmonary Function Testing* | |
| FEV1(liter) | 2.3 (1.3-3.4) |
| DLCO (% theo.) | 70 (47-103) |
*
Median (range)
WHO PS: World Health Organisation performance status; N: number of patients; FEV1: Forced Expiratory Volume in one second; DLCO: diffusing capacity for carbon monoxide ; % theo: % of the theoretical value.